Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Submitted by
admin
on November 7, 2011 - 9:15pm
Source:
Bloomberg
News Tags:
Erbitux
Bristol-Myers Squibb
ImClone
Eli Lilly
head and neck cancer
Headline:
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Do Not Allow Advertisers to Use My Personal information
